Saudi Pharmaceutical Industries and Medical Appliances Corporation

TADAWUL:2070.SR

33.95 (SAR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income -9-146.2531.555155.108-449.394102.829197.366376.692357.054316.853266.821232.633211.433176.525154.804128.269121.864105.033
Depreciation & Amortization 7990.27388.10687.419103.86753.00241.03925.73325.2924.93830.92421.93821.837-7.43829.72929.63718.61915.929
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital -2722.33413.783-183.486333.698-184.7246.25-208.642-338.187-177.706-142.391-100.349-94.784-79.047-6.877-36.92607.115
Accounts Receivables -161.739172.69213.02-51.66658.2843.55651.98-219.652-265.275-143.279-86.354-37.961000000
Inventory -143.025172.69218.024-44.34760.356-35.089-96.76-60.528-79.2221.201-22.148-62.388-21.007-4.8817.876-13.970-12.616
Accounts Payables 103.539-57.959-14.266-105.853157.601-103.75363.50689.87889.196000000000
Other Working Capital -70.775-285.09-2.99518.3857.456-49.438-12.476-18.34-82.887-55.628-120.243-37.961-73.777-74.166-14.753-22.956019.731
Other Non Cash Items 249-70.555-46.732-49.305361.82-183.332-42.021-367.284-395.523-273.6142.396-6.638-29.66845.941-53.206-11.685-20.249-28.406
Operating Cash Flow 47-124.19886.7139.736349.991-80.503155.3449.408-38.46943.239157.75147.584108.819135.982124.45109.295120.23499.671
Investing Activities:
Investments In Property Plant And Equipment -117.355-84.638-83.879-183.361-341.592-281.045-234.666-310.459-288.102-46.919-47.757-44.858-34.25-17.812-21.749-14.4970-39.749
Acquisitions Net 4.3654.356-2.416-2.13-36.90415.46542.616-103.28325.628000000000
Purchases Of Investments -70.5-45-145.308-593.211-20-42.7080-10.027-27.6440-13.3130000000
Sales Maturities Of Investments -4.365570.889341.463589.49312.436239.22374.765240.181243.584000000000
Other Investing Activites 15.85532.59231.61642.62242.832-42.087-143.822-293.534.44323.0320.3-105.889-17.828-6.012-0.091-158.022-23.748-0.65
Investing Cash Flow -172478.199141.476-146.587-343.228-42.087-143.822-293.534.44323.032-60.77-150.747-52.078-23.824-21.84-172.519-23.748-40.399
Financing Activities:
Debt Repayment -43.943-215.105-61.545-139.548-201.809-214.082-19.625-483.177-281.456000000000
Common Stock Issued 000000000000000000
Common Stock Repurchased -8.002000000000-144.150000000
Dividends Paid -0.461-70.738-118.11-58.975-118.127-176.028-116.487-87.353-153.421-63.977-144.15-148.505-107.82-106.828-80.394000
Other Financing Activities 0.812-25.011-61.297277.378424.84533.64-55.97468.363150.138-60.103143.92420.1681.536235.22421.733-44.424-56.829-48.879
Financing Cash Flow -32-310.854-240.95278.854104.90933.64-55.97468.363150.138-60.103-144.375-128.336-106.284128.397-58.661-44.424-56.829-48.879
Other Information:
Effect Of Forex Changes On Cash -16.146-37.4618.34513.105378.973000255.691139.579118.7360000000
Net Change In Cash -175.349341.035325.245289.19490.645-88.95-44.448184.241371.803145.74671.34-131.5-49.544240.55443.949-107.64839.65710.393
Cash At End Of Period 160670.699659.327668.162757.946267.733356.683439.932511.382279.158237.471166.132297.631347.175106.62262.673170.32130.663